Compare
Beyond Air, Inc. vs INVO Fertility, Inc. vs InspireMD, Inc. vs Encision Inc
| Latest fiscal year | Beyond Air, Inc. XAIR | INVO Fertility, Inc. IVF | InspireMD, Inc. NSPR | Encision Inc ECIALast annual report: year ended 2025-03-31 |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2025-12-31 | 2025-12-31 | 2025-03-31 |
| Revenue | $7.68M | $6.84M | $8.98M | $6.56M |
| Revenue growth (YoY) | +107.3% | +4.7% | +28.1% | -0.5% |
| Gross margin | 3.3% | n/a | 29.5% | 53.6% |
| Operating margin | -378.2% | -105.8% | -552.6% | -2.6% |
| Net margin | -433.0% | -340.9% | -543.3% | -3.4% |
| Net income | -$33.25M | -$23.32M | -$48.79M | -$220.2K |
| EPS (Diluted) | -$4.01 | -$214.64 | -$0.76 | -$0.02 |
| Operating cash flow | -$18.14M | -$7.01M | -$35.10M | -$54.9K |
| Free cash flow | -$19.17M | -$7.06M | -$36.77M | -$109.4K |
| Cash & equivalents | $6.74M | n/a | $8.94M | $257.4K |
| Total assets | $35.38M | $20.22M | $69.40M | $3.67M |
| Total liabilities | $29.18M | $13.00M | $14.20M | $2.02M |
| Shareholders' equity | $6.13M | $7.22M | $55.20M | $1.65M |
| Return on year-end equity | -542.8% | -322.8% | -88.4% | -13.3% |
| Shares outstanding | 11.79M | 477.4K | 43.53M | 11.88M |
Revenue, most recent five fiscal years
| Fiscal year | Beyond Air, Inc. | INVO Fertility, Inc. | InspireMD, Inc. | Encision Inc |
|---|---|---|---|---|
| Latest | $7.68M Ended 2026-03-31 | $6.84M Ended 2025-12-31 | $8.98M Ended 2025-12-31 | $6.56M Ended 2025-03-31 |
| 1 year earlier | $3.71M Ended 2025-03-31 | $6.53M Ended 2024-12-31 | $7.01M Ended 2024-12-31 | $6.59M Ended 2024-03-31 |
| 2 years earlier | $1.16M Ended 2024-03-31 | $3.02M Ended 2023-12-31 | $6.21M Ended 2023-12-31 | $7.35M Ended 2023-03-31 |
| 3 years earlier | n/a | n/a | $5.17M Ended 2022-12-31 | $7.67M Ended 2022-03-31 |
| 4 years earlier | n/a | n/a | $4.50M Ended 2021-12-31 | $7.54M Ended 2021-03-31 |